High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: A 7-year experience

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 5, 2012, Pages 1480-1485

  Aluwini, Shafak ^a   Van Rooij, Peter H ^a   Kirkels, Wim J ^a   Jansen, Peter P ^a   Praag, John O ^a   Bangma, Chris H ^a   Kolkman Deurloo, Inger Karine K ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Brachytherapy; Prostate cancer; Radiotherapy; Toxicity

Indexed keywords

BONE METASTASIS; BRACHYTHERAPY; CLINICAL OUTCOME; DISEASE-SPECIFIC SURVIVALS; FREEDOM FROM BIOCHEMICAL FAILURES; HIGH-DOSE-RATE BRACHYTHERAPY; LOCAL RECURRENCE; OVERALL SURVIVAL; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; RADIATION ONCOLOGY;

DISEASES; ONCOLOGY; TOXICITY;

RADIOTHERAPY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMICAL FAILURE FREE SURVIVAL; BLADDER PERFORATION; BONE METASTASIS; BRACHYTHERAPY; CANCER RECURRENCE; CANCER RISK; DISEASE SPECIFIC SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; ULTRASOUND; UROGENITAL TRACT DISEASE;

AGED; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84863631545     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.10.055     Document Type: Article

References (20)

1. S.T. Peeters, W.D. Heemsbergen, and W.L. van Putten Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy Int J Radiat Oncol Biol Phys 61 2005 1019 1034
2. A.A. Martinez, G. Gustafson, and J. Gonzalez Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer Int J Radiat Oncol Biol Phys 53 2002 316 327
3. R.M. Galalae, A. Martinez, and T. Mate Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1048 1055
4. M. Sato, T. Mori, and S. Shirai High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer Int J Radiat Oncol Biol Phys 72 2008 1002 1009
5. I.K. Kolkman-Deurloo, M.A. Roos, and S. Aluwini HDR monotherapy for prostate cancer: A simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation Radiother Oncol 98 2011 192 197
6. G.W. Hull, F. Rabbani, and F. Abbas Cancer control with radical prostatectomy alone in 1,000 consecutive patients J Urol 167 2002 528 534
7. J. Rassweiler, O. Seemann, and M. Schulze Laparoscopic versus open radical prostatectomy: A comparative study at a single institution J Urol 169 2003 1689 1693
8. D.A. Kuban, H.D. Thames, and L.B. Levy Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era Int J Radiat Oncol Biol Phys 57 2003 915 928
9. J. Whitson, and S. Porten Outcomes of active surveillance for early prostate cancer J Urol 183 Suppl 2010 2032
10. I.C. Hsu, B. Pickett, and K. Shinohara Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: Potential for dose escalation Int J Radiat Oncol Biol Phys 46 2000 851 858
11. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105
12. J.F. Fowler The radiobiology of prostate cancer including new aspects of fractionated radiotherapy Acta Oncol 44 2005 265 276
13. D.J. Demanes, R.R. Rodriguez, and L. Schour High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results Int J Radiat Oncol Biol Phys 61 2005 1306 1316
14. E.M. Horwitz, L.B. Levy, and H.D. Thames Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: A multiinstitutional pooled analysis Cancer 107 2006 1496 1502
15. A. Toledano, L. Chauveinc, and T. Flam PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: A study of 295 patients with a minimum 3-year followup Brachytherapy 5 2006 122 126
16. F. Bachand, A.G. Martin, and L. Beaulieu An eight-year experience of HDR brachytherapy boost for localized prostate cancer: Biopsy and PSA outcome Int J Radiat Oncol Biol Phys 73 2009 679 684
17. Hinnen KA, Monninkhof EM, Battermann JJ, et al. Prostate specific antigen bounce is related to overall survival in prostate brachytherapy. Int J Radiat Oncol Biol Phys. E-pub. February 6th, 2011.
18. D.J. Demanes, A.A. Martinez, and M. Ghilezan High-dose-rate monotherapy: Safe and effective brachytherapy for patients with localized prostate cancer Int J Radiat Oncol Biol Phys 81 2011 1286 1292
19. M.J. Zelefsky, K.E. Wallner, and C.C. Ling Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer J Clin Oncol 17 1999 517 522
20. S. Aluwini, W. Kirkels, and S. Hofstra Early experience in CT-planned HDR brachytherapy of early stage prostate cancer as monotherapy Radiother Oncol 88 Suppl. 2 2008 s323